Form 8-K - Current report:
SEC Accession No. 0001104659-09-017966
Filing Date
2009-03-16
Accepted
2009-03-16 16:22:07
Documents
5
Period of Report
2009-03-16
Items
Item 2.02: Results of Operations and Financial Condition
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K a09-7793_18k.htm 8-K 26945
2 EX-99.1 a09-7793_1ex99d1.htm EX-99.1 125976
3 EX-99.2 a09-7793_1ex99d2.htm EX-99.2 7015
4 GRAPHIC g77931moi001.gif GRAPHIC 3257
5 GRAPHIC g77931mmi001.gif GRAPHIC 3254
  Complete submission text file 0001104659-09-017966.txt   170890
Mailing Address 300 ELLIOTT AVENUE WEST SUITE 500 SEATTLE WA 98119-4114
Business Address 7000 SHORELINE COURT SUITE 270 SO. SAN FRANCISCO CA 94080 2062862501
PONIARD PHARMACEUTICALS, INC. (Filer) CIK: 0000755806 (see all company filings)

EIN.: 911261311 | State of Incorp.: WA | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-16614 | Film No.: 09684596
SIC: 2834 Pharmaceutical Preparations